Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-04 Sale |
2021-08-06 6:08 pm |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
13,777 | $53.23 | $733,317 | 85,471 (Direct) |
View |
| 2021-02-17 Purchase |
2021-02-18 8:33 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
8,000 | $62.5 | $500,000 | 322,270 (Direct) |
View |
| 2021-02-17 Purchase |
2021-02-18 6:21 pm |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
16,000 | $62.5 | $1,000,000 | 21,000 (Direct) |
View |
| 2021-02-17 Sale |
2021-02-17 5:36 pm |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
3,450,000 | $60.47 | $208,617,360 | 31,060,971 (Indirect) |
View |
| 2021-01-26 Purchase |
2021-01-26 4:05 pm |
Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma Inc. 10% Owner |
14,428,836 | $0 | $0 | 1,000 (Direct) |
View |
| 2020-12-28 Sale |
2020-12-29 9:14 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
19,500 | $69.6 | $1,357,184 | 355,876 (Direct) |
View |
| 2020-12-21 Sale |
2020-12-23 5:35 pm |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
60,401 | $65.32 | $3,945,137 | 45,860 (Direct) |
View |
| 2020-12-18 Sale |
2020-12-21 4:05 pm |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
30,000 | $65.07 | $1,952,021 | 106,261 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-17 4:05 pm |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
31,443 | $60.38 | $1,898,417 | 189,649 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-02 4:17 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $51.52 | $515,204 | 282,493 (Direct) |
View |
| 2020-06-03 Sale |
2020-12-02 4:05 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
784 | $30.04 | $23,549 | 261,399 (Direct) |
View |
| 2020-11-24 Sale |
2020-11-25 9:54 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
5,000 | $47.04 | $235,181 | 539,310 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-17 Option Award |
2021-08-26 5:14 pm |
N/A 2031-08-16 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
49,869 | $0 | 49,869 (Direct) |
View |
| 2021-08-16 Tax Withholding |
2021-08-18 4:10 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
1,028 | $49.48 | 332,829 (Direct) |
View |
| 2021-08-16 Exercise |
2021-08-18 4:10 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
4,974 | $0 | 332,829 (Direct) |
View |
| 2021-08-16 Tax Withholding |
2021-08-18 4:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
3,730 | $49.48 | 7,617,360 (Direct) |
View |
| 2021-08-16 Exercise |
2021-08-18 4:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
15,046 | $0 | 7,617,360 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 6:08 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
13,777 | $17 | 85,471 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 6:08 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
13,777 | $0 | 85,471 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 8:00 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 7:38 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | Lo Andrew Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 7:21 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 7:16 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 7:15 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 7:08 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | SAUNDERS BRENT L Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 7:03 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 6:51 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Chairman of R&D |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 6:47 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 6:45 pm |
N/A 2031-06-16 |
BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director |
38,895 | $0 | 38,895 (Direct) |
View |
| 2021-05-16 Tax Withholding |
2021-05-18 6:29 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
3,731 | $53.66 | 7,621,090 (Direct) |
View |
| 2021-05-16 Exercise |
2021-05-18 6:29 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
15,048 | $0 | 7,621,090 (Direct) |
View |
| 2021-05-16 Tax Withholding |
2021-05-18 6:28 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
862 | $53.66 | 333,857 (Direct) |
View |
| 2021-05-16 Exercise |
2021-05-18 6:28 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
4,976 | $0 | 333,857 (Direct) |
View |
| 2021-03-01 Tax Withholding |
2021-03-03 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
524 | $71.91 | 1,204,764 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director |
1,521 | $0 | 1,204,764 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 8:33 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
1,710 | $0 | 322,270 (Direct) |
View |
| 2021-02-16 Tax Withholding |
2021-02-18 8:33 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
592 | $64.98 | 322,270 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-18 7:45 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
16,000 | $62.5 | 7,586,515 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 7:45 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
5,129 | $0 | 7,586,515 (Direct) |
View |
| 2021-02-16 Tax Withholding |
2021-02-18 7:45 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
2,139 | $64.98 | 7,586,515 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:51 pm |
N/A 2031-02-09 |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
85,889 | $0 | 85,889 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:45 pm |
N/A 2031-02-09 |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
264,277 | $0 | 264,277 (Direct) |
View |
| 2020-11-24 Ownership |
2021-02-12 4:15 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
740,650 | $0 | 5,888,121 (Indirect) |
View |
Ownership |
2021-02-12 4:15 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
0 | $0 | 5,888,121 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 8:40 pm |
N/A 2030-05-27 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
159,404 | $0 | 159,404 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
7,500 | $17 | 355,876 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
6,000 | $0.16 | 355,876 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
6,000 | $0.34 | 355,876 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 9:14 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
19,500 | $0 | 355,876 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:05 pm |
N/A 2030-04-01 |
BridgeBio Pharma Inc. | BBIO | Sinha Uma Chief Scientific Officer |
25,461 | $0 | 25,461 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:05 pm |
N/A 2030-04-01 |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
9,792 | $0 | 9,792 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
29,277 | $17 | 189,649 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 4:05 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
29,277 | $0 | 189,649 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 4:17 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $1.05 | 282,493 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 4:17 pm |
2020-05-19 2029-09-24 |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
10,000 | $0 | 282,493 (Direct) |
View |
| 2020-11-24 Exercise |
2020-11-25 9:54 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
5,000 | $17 | 539,310 (Direct) |
View |
| 2020-11-24 Exercise |
2020-11-25 9:54 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
5,000 | $0 | 539,310 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 8:44 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | YAU YI CHING Chief Accounting Officer |
10,986 | $0 | 25,454 (Direct) |
View |
| 2020-11-16 Tax Withholding |
2020-11-18 8:44 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | YAU YI CHING Chief Accounting Officer |
1,900 | $44.33 | 25,454 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:51 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
5,129 | $0 | 7,777,304 (Direct) |
View |
| 2020-11-16 Tax Withholding |
2020-11-18 7:51 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
1,774 | $44.33 | 7,777,304 (Direct) |
View |